American Journal of Cancer Prevention
ISSN (Print): 2328-7314 ISSN (Online): 2328-7322 Website: Editor-in-chief: Nabil Abdel-Hamid
Open Access
Journal Browser
American Journal of Cancer Prevention. 2015, 3(3), 65-67
DOI: 10.12691/ajcp-3-3-5
Open AccessResearch Article

Association between of BMI and Blood Groups with Breast Cancer Incidence among Women of West Iran: A Case-control Study

Mehrdad Payandeh1, Babak Shazad1, Masoud Sadeghi2, 3, , Nahid Bahari2, 3 and Edris Sadeghi2, 3

1Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

Pub. Date: May 31, 2015
(This article belongs to the Special Issue Advances in Breast Cancer)

Cite this paper:
Mehrdad Payandeh, Babak Shazad, Masoud Sadeghi, Nahid Bahari and Edris Sadeghi. Association between of BMI and Blood Groups with Breast Cancer Incidence among Women of West Iran: A Case-control Study. American Journal of Cancer Prevention. 2015; 3(3):65-67. doi: 10.12691/ajcp-3-3-5


Background: Breast cancer accounts about one fifth of all female malignancy. This cancer is the leading cause of death in high income countries and second leading cause in low and middle income countries. The aim of study is to evaluate a number of factors in the patients of breast cancer compared to controls in West Iran and correlation of them with breast cancer incidence. Patients and Methods: In 2014, 76 patients with breast cancer and invasive ductal carcinoma (cases) and 81 age and sex matched-controls randomly were interred to our study. We compared blood groups, BMI, age at the first menarche and hypertension in both groups. Results: In case group, the frequency of A+, O+, B+ and AB+ was 40.8%, 28.9%, 14.5% and 9.2%, respectively. Also, the frequency of A-, B-, AB-, O- with each other was 6.5%. In control group, A+, O+, B+ and AB+ was 27.2%, 34.6%, 21% and 8.6%, respectively. The frequency of BMI in two groups was almost similar. Of 76 patients, 13.2% had hypertension and also of 81 controls, 16% had hypertension. The mean age t the first menarche for cases was 13.75 years and for controls was 13.77 years. There was significant correlation between of these variables with breast cancer incidence (P>0.05). Conclusions: Blood groups, BMI, age at the first menarche and hypertension are not singly risk factors for breast cancer incidence, but probably combination of them can increases breast cancer incidence. In our opinion, the link between of breast cancer and listed variables is unexplained.

blood group BMI breast cancer case-control study

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Payandeh M, Khodarahmi R, Sadeghi M, Sadeghi E. Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature, Iran J Cancer Prev, 8 (2), 125-8, 2015.
[2]  Namiranian N, Moradi-Lakeh M, Razavi-Ratki SK, Doayie M, Nojomi M. Risk factors of breast cancer in the Eastern Mediterranean Region: a systematic review and meta-analysis, Asian Pac J Cancer Prev, 15 (21), 9535-41, 2014.
[3]  Wafa M, Bilal A, Ijaz J, et al. Breast cancer: major risk factors and recent developments in treatment, Asian Pac J Cancer Prev, 15, 3353-8, 2014.
[4]  Bidgoli SA, Azarshab H. Role of vitamin D deficiency and lack of sun exposure in the incidence of premenopausal breast cancer: a case control study in Sabzevar, Iran, Asian Pac J Cancer Prev, 15 (8), 3391-6, 2014.
[5]  Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N, Mohseni SM, Montazeri A, et al. Twenty years of breast cancer in Iran: down staging without a formal screening program, Ann Oncol, 22 (1), 93-7, 2012.
[6]  Jackson RS, Black JH 3rd, Lum YW, Schneider EB, Freischlag JA, Perler BA, et al. Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy, J Vasc Surg, 55 (5), 1306-12, 2012.
[7]  Payandeh M, Sadeghi E, Sadeghi M, Eskandar AM. Different Presentation of Treatment in Carcinomatous Meningitis of Breast Cancer: Report of 3 Cases, American Journal of Cancer Prevention, 3 (1), 4-7, 2015.
[8]  Payandeh M, Sadeghi M, Sadeghi E, koohian AK. Comparison of IHC, FISH, ER and PR in Breast Cancer in Western Iran, American Journal of Cancer Prevention, 2 (2), 37-41, 2014.
[9]  Flavarjani AH, Hedayatpour B, Bashardoost N, Nourian SM. Study of the association between blood types and breast cancer among Isfahanian women with breast cancer, Adv Biomed Res, 3, 43, 2014.
[10]  Stamatakos M, Kontzoglou K, Safioleas P, Safioleas C, Manti C, et al. Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor, Int Semin Surg Oncol, 6, 14-18, 2009.
[11]  Cihan YB. Significance of ABO-Rh blood groups in response and prognosis in breast cancer patients treated with radiotherapy and chemotherapy, Asian Pac J Cancer Prev, 15 (9), 4055-60, 2014.
[12]  Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival, Int J Cancer, 130 (9), 2129-37, 2012.
[13]  Minatoya M, Kutomi G, Shima H, Asakura S, Otokozawa S, Ohnishi H, et al. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study, Asian Pac J Cancer Prev, 15 (19), 8325-30, 2014.
[14]  Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, et al. Prognostic value of body mass index in locally advanced breast cancer, Clin Cancer Res, 14, 1718-1725, 2008.
[15]  Hede K. Fat may fuel breast cancer growth, J Natl Cancer Inst, 100, 298-299, 2008.
[16]  Sellahewa C, Nightingale P, Carmichael AR. Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer, Int Semin Surg Oncol, 5, 2, 2008.
[17]  Wu AH, Ziegler RG, Pike MC, Nomura AM, West DW, Kolonel LN, et al. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans, Br J Cancer, 73 (5), 680-6, 1996.
[18]  Orgéas CC, Hall P, Rosenberg LU, Czene K. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer, Breast Cancer Res, 10 (6), R107, 2008.
[19]  Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrère CH, Grobbee DE. Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer, J Hypertens, 18 (3), 249-54, 2000.
[20]  Pereira A, Garmendia ML, Alvarado ME, Albala C. Hypertension and the risk of breast cancer in Chilean women: a case-control study, Asian Pac J Cancer Prev, 13 (11), 5829-34, 2012.
[21]  Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women, Hypertension, 34 (2), 320-325, 1999.
[22]  Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, et al. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose, Cancer Causes Control, 5 (2), 167-176, 1994.
[23]  Tornberg SA, Holm LE, Cartensen JM. Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight and blood pressure, Acta Oncol, 27, 31-37, 1988.
[24]  Manjer J, Kaaks R, Riboli E, Berglund G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project, Eur J Cancer Prev, 10, 33-42, 2001.
[25]  Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland, J Hum Hypertens, 19, 373-379, 2005.